Concert Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-9,818
Closed -$548K 36
2017
Q2
$548K Sell
9,818
-24,501
-71% -$1.33M 0.53% 57
2017
Q1
$2.01M Sell
34,319
-2,574
-7% -$141K 0.46% 48
2016
Q4
$2.17M Sell
36,893
-28,298
-43% -$1.55M 0.48% 44
2016
Q3
$3.52M Buy
65,191
+885
+1% +$56.8K 0.43% 41
2016
Q2
$4.73M Buy
64,306
+7,138
+12% +$504K 0.64% 24
2016
Q1
$3.65M Sell
57,168
-1,229
-2% -$77.5K 0.49% 39
2015
Q4
$4.02M Sell
58,397
-4,906
-8% -$324K 0.54% 36
2015
Q3
$3.76M Sell
63,303
-15,469
-20% -$981K 0.51% 35
2015
Q2
$5.24M Sell
78,772
-4,013
-5% -$264K 0.68% 23
2015
Q1
$2.96M Buy
82,785
+6,013
+8% +$376K 0.85% 15
2014
Q4
$4.54M Buy
76,772
+37,757
+97% +$2.13M 0.69% 18
2014
Q3
$1.99M Sell
39,015
-3,302
-8% -$165K 0.27% 49
2014
Q2
$1.95M Sell
42,317
-819
-2% -$40.4K 0.24% 51
2014
Q1
$2.23M Sell
43,136
-96
-0.2% -$5.11K 0.28% 37
2013
Q4
$2.3M Sell
43,232
-2,282
-5% -$116K 0.29% 34
2013
Q3
$2.11M Sell
45,514
-797
-2% -$35K 0.3% 32
2013
Q2
$2.07M Buy
+46,311
New +$2.01M 0.31% 28

Other funds holding BMY

Concert Wealth Management's BMY Position: Q3 2017 in Review

Concert Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 9,818 shares — an estimated $548K sold.

Concert Wealth Management first reported a position in BMY in Q2 2013 and held it in 17 quarters. The position peaked at $5.24M in Q2 2015. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Concert Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
  • Concert Wealth Management sold 9,818 Bristol-Myers Squibb shares in Q3 2017, an estimated $548K.
  • Concert Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 17 quarters.
  • Concert Wealth Management's Bristol-Myers Squibb position peaked at $5.24M in Q2 2015.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Concert Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.